Should Biotechnology Stock Mirati Therapeutics Inc (MRTX) Be in Your Portfolio Thursday?

Thursday, September 23, 2021 11:33 AM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Mirati Therapeutics Inc (MRTX) Be in Your Portfolio Thursday?

Mirati Therapeutics Inc (MRTX) is around the bottom of the Biotechnology industry according to InvestorsObserver. MRTX received an overall rating of 31, which means that it scores higher than 31 percent of all stocks. Mirati Therapeutics Inc also achieved a score of 26 in the Biotechnology industry, putting it above 26 percent of Biotechnology stocks. Biotechnology is ranked 85 out of the 148 industries.

MRTX has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on MRTX!

See Full MRTX Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 31 means the stock is more attractive than 31 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Mirati Therapeutics Inc Stock Today?

Mirati Therapeutics Inc (MRTX) stock is trading at $169.35 as of 11:32 AM on Thursday, Sep 23, an increase of $2.25, or 1.35% from the previous closing price of $167.10. The stock has traded between $168.54 and $174.90 so far today. Volume today is 370,966 compared to average volume of 480,098. Click Here to get the full Stock Report for Mirati Therapeutics Inc stock.